Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19-Reference-Cited by-同舟云学术

Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19

Published:2022-04-05 Issue:13 Volume:327 Page:1236
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Gupta Anil¹,Gonzalez-Rojas Yaneicy²,Juarez Erick³,Crespo Casal Manuel⁴,Moya Jaynier⁵,Rodrigues Falci Diego⁶,Sarkis Elias⁷,Solis Joel⁸,Zheng Hanzhe⁹,Scott Nicola¹⁰,Cathcart Andrea L.⁹,Parra Sergio⁹,Sager Jennifer E.⁹,Austin Daren¹⁰,Peppercorn Amanda¹¹,Alexander Elizabeth⁹,Yeh Wendy W.⁹,Brinson Cynthia¹²,Aldinger Melissa⁹,Shapiro Adrienne E.¹³¹⁴,Free Almena¹⁵,Johnson Kimball¹⁵,Cordasco Edward¹⁵,Little Raymond¹⁵,Bajwa Ali¹⁵,Doshi Ankur¹⁵,Focil Augusto¹⁵,Hussain Rubaba (Rubie)¹⁵,Bostick Greg¹⁵,Somodevilla Guillermo¹⁵,Ali Hasan¹⁵,Kowalczyk John¹⁵,Mittal Shilpi¹⁵,Caso Jorge¹⁵,Goisse Marcy¹⁵,Espinal Ladynez¹⁵,Zepeda Luis¹⁵,Nguyen Thinh¹⁵,Martinez Luis¹⁵,Alvarez German¹⁵,Pucillo Ronald¹⁵,Seep Michael¹⁵,Parikh Naval¹⁵,Escobar Victor¹⁵,Curra Armando¹⁵,Dal Maso Vinicius¹⁵,O'Mahony John¹⁵,Ramacciotti Eduardo¹⁵,Diaz Jorge¹⁵,Luz Kleber¹⁵,Ruane Peter¹⁵,Mochlera Bharat¹⁵,Roldan Sanchez Juan¹⁵,Hernandez Luis¹⁵,Fernandez Alfredo¹⁵,Leavitt Glenn¹⁵,Azizad Masoud¹⁵,Afzal Haider¹⁵,Fatakia Adil¹⁵,Narejos Perez Silvia¹⁵,Stadnik Claudio Marcel¹⁵,Gorgos Linda¹⁵,Sachdeva Yessica¹⁵,Segura Patricia¹⁵,Quandros Carlos¹⁵,Perry Russell¹⁵,Sher Lawrence¹⁵,

Affiliation:

1. Albion Finch Medical, William Osler Health Centre, Toronto, Ontario, Canada

2. Optimus U Corp, Miami, Florida

3. Florida International Medical Research, Miami

4. Álvaro Cunqueiro Hospital, IIS Galicia Sur, Vigo, Pontevedra, Spain

5. Pines Care Research Center, Pembroke Pines, Florida

6. Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil

7. Sarkis Clinical Trials, Gainesville, Florida

8. Centex Studies, McAllen, Texas

9. Vir Biotechnology Inc, San Francisco, California

10. GlaxoSmithKline, Brentford, England

11. GlaxoSmithKline, Cambridge, Massachusetts